Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥50 years: Evidence from an individual patient data meta-analysis

Journal of Clinical Oncology

Volumn 33, Issue 4, 2015, Pages 349-356

  Phi, Xuan Anh ^a   Houssami, Nehmat ^c   Obdeijn, Inge Marie ^b   Warner, Ellen ^d   Sardanelli, Francesco ^f   Leach, Martin O ^h   Riedl, Christopher C ⁱ   Trop, Isabelle ^e   Tilanus Linthorst, Madeleine M A ^b   Mandel, Rodica ^d   Santoro, Filippo ^g   Kwan Lim, Gek ^h   Helbich, Thomas H ⁱ   De Koning, Harry J ^b   Van Den Heuvel, Edwin R ^a   De Bock, Geertruida H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e Musculoskeletal Imaging Department   (Canada)

^f UNIVERSITY OF MILAN   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER SCREENING; CLINICAL TRIAL (TOPIC); DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MAMMOGRAPHY; META ANALYSIS; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; AGED; BREAST NEOPLASMS; EARLY DIAGNOSIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HETEROZYGOTE; MIDDLE AGED; MUTATION; PROCEDURES; REPRODUCIBILITY; YOUNG ADULT;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; MUTATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84921927677     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.6232     Document Type: Article

References (43)

1. Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25: 1329-1333, 2007
2. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
3. van der Kolk DM, de Bock GH, Leegte BK, et al: Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: High cancer incidence at older age. Breast Cancer Res Treat 124:643-651, 2010
4. Peer PG, van Dijck JA, Hendriks JH, et al: Age-dependent growth rate of primary breast cancer. Cancer 71:3547-3551, 1993
5. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996
6. Tilanus-Linthorst MM, Obdeijn IM, Hop WC, et al: BRCA1 mutation and young age predict fast breast cancer growth in the dutch, united kingdom, and canadian magnetic resonance imaging screening trials. Clin Cancer Res 13:7357-7362, 2007
7. Warner E, Messersmith H, Causer P, et al: Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671-679, 2008
8. McLaughlin S, Mittendorf EA, Bleicher RJ, et al: The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer-Where are we now? Ann Surg Oncol 21: 28-36, 2014
9. Passaperuma K, Warner E, Causer PA, et al: Long-term results of screening with magnetic resonance imaging in women with BRCA mutations. Br J Cancer 107:24-30, 2012
10. Rijnsburger AJ, Obdeijn IM, Kaas R, et al: BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol 28:5265-5273, 2010
11. Leach MO, Boggis CR, Dixon AK, et al: Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778, 2005
12. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, et al: Magnetic resonance imaging of ductal carcinoma in situ: What is its clinical application? A review. Am J Surg 198:262-269, 2009
13. Obdeijn IM, Loo CE, Rijnsburger AJ, et al: Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Res Treat 119:399-407, 2010
14. Lord SJ, Lei W, Craft P, et al: A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905-1917, 2007
15. Hutton J, Walker LG, Gilbert FJ, et al: Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: The MARIBS study. Br J Cancer 104:578-586, 2011
16. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007
17. National Institute for Health and Care Excellence: NICE Guidelines CG 164: Familial breast cancer. https://www.nice.org.uk/guidance/cg164
18. Zonderland HM, van Vegchel T, van Asperen CJ, et al: Richtlijn Mammacarcinoom. https://www .fysionet.nl/kennisplein/vakinhoud/multidisciplinairerichtlijnen/ mammacarcinoom.pdf
19. Sardanelli F, Boetes C, Borisch B, et al: Magnetic resonance imaging of the breast: Recommendations from the EUSOMA Working Group. Eur J Cancer 46:1296-1316, 2010
20. Elmore JG, Armstrong K, Lehman CD, et al: Screening for breast cancer. JAMA 293:1245-1256, 2005
21. Sardanelli F, Podo F, Santoro F, et al: Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 Study): Final results. Invest Radiol 46:94-105, 2011
22. Sardanelli F, Giuseppetti GM, Canavese G, et al: Indications for breast magnetic resonance imaging: Consensus document "attualita in senologia," Florence 2007. Radiol Med 113:1085-1095, 2008
23. Singer CF, Tea MK, Pristauz G, et al: Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families [in German]. Wien Klin Wochenschr 124:334-339, 2012
24. Whiting PF, Rutjes AW, Westwood ME, et al: QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529-536, 2011
25. Hagen AI, Kvistad KA, Maehle L, et al: Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast 16:367-374, 2007
26. Kuhl C, Weigel S, Schrading S, et al: Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: The EVA trial. J Clin Oncol 28:1450-1457, 2010
27. Kuhl CK, Schrading S, Leutner CC, et al: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476, 2005
28. Lehman CD, Blume JD, Weatherall P, et al: Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898-1905, 2005
29. Lehman CD, Isaacs C, Schnall MD, et al: Cancer yield of mammography, MR, and US in high-risk women: Prospective multi-institution breast cancer screening study. Radiology 244:381-388, 2007
30. Riedl CC, Ponhold L, Flöry D, et al: Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144-6152, 2007
31. Saunders CM, Peters G, Longman G, et al: A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western Australia. Med J Aust 191:330-333, 2009
32. Schmutzler RK, Rhiem K, Breuer P, et al: Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev 15:483-489, 2006
33. Trop I, Lalonde L, Mayrand MH, et al: Multimodality breast cancer screening in women with a familial or genetic predisposition. Curr Oncol 17:28-36, 2010
34. Weinstein SP, Localio AR, Conant EF, et al: Multimodality screening of high-risk women: A prospective cohort study. J Clin Oncol 27:6124-6128, 2009
35. Cortesi L, Turchetti D, Marchi I, et al: Breast cancer screening in women at increased risk according to different family histories: An update of the Modena Study Group experience. BMC Cancer 6:210, 2006
36. Houssami N, Ciatto S, Irwig L, et al: The comparative sensitivity of mammography and ultrasound in women with breast symptoms: An agespecific analysis. Breast 11:125-130, 2002
37. Bigenwald RZ, Warner E, Gunasekara A, et al: Is mammography adequate for screening women with inherited BRCA mutations and low breast density? Cancer Epidemiol Biomarkers Prev 17:706-711, 2008
38. Kriege M, Brekelmans CT, Obdeijn IM, et al: Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat 100:109-119, 2006
39. Heijnsdijk EA, Warner E, Gilbert FJ, et al: Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21:1458-1468, 2012
40. Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, et al: Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. J Natl Cancer Inst 105:1314-1321, 2013
41. de Bock GH, Vermeulen KM, Jansen L, et al: Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness. Br J Cancer 108:1579-1586, 2013
42. Kuhl CK, Schrading S, Bieling HB, et al: MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 370:485-492, 2007
43. Houssami N, Turner R, Macaskill P, et al: An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 32:392-401, 2014